×
About 766 results

ALLMedicine™ Oncology Treatment Center

Research & Reviews  319 results

The impact of a tailored follow-up intervention on comprehensive geriatric assessment i...
https://doi.org/10.1016/j.jgo.2020.07.011
Journal of Geriatric Oncology; Ørum M, Eriksen SV et. al.

Jul 30th, 2020 - Comprehensive Geriatric Assessment (CGA) can identify health problems in older persons. In addition, CGA includes intervention towards the identified problems. With follow up, more problems may be identified and the interventions can be adjusted. ...

Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300499
Clinical Pharmacology and Therapeutics; Holstein SA, Vose JM

Jun 2nd, 2020 - Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.|2020|Holstein SA,Vose JM,|

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Changing Oncology Treatment Paradigms in the COVID-19 Pandemic.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224660
Clinical Colorectal Cancer; Lou E, Subramanian S

May 18th, 2020 - Changing Oncology Treatment Paradigms in the COVID-19 Pandemic.|2020|Lou E,Subramanian S,|

Cautious optimism-the current role of immunotherapy in gastrointestinal cancers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193996
Current Oncology (Toronto, Ont.); Mendis S, Gill S

May 5th, 2020 - Immunotherapy has been described as the "fourth pillar" of oncology treatment, in conjunction with surgery, chemotherapy, and radiotherapy. However, the role of immunotherapy in gastrointestinal tumours is still evolving. Data for checkpoint inhib...

see more →

Guidelines  29 results

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive summary of an ASTRO Consensus Paper
https://www.practicalradonc.org/article/S1879-8500(18)30353-9/abstract
Wright,J.,et al

Jan 20th, 2019 - Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring perfor...

ASTRO Consensus Statement on Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive Summary
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Contouring-Consensus-Guidance-Document

Jan 20th, 2019 - This document provides tabled recommendations for normal tissues contouring during external beam treatment planning for each anotomical site in all definitive cases and those that should be considered in specific clinical scenarios. Additionally, ...

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2720582
Foster,J.

Jan 10th, 2019 - Comparative analysis revealed CRS/HIPEC to be safe, often safer across the spectrum of NSQIP safety metrics when compared with similar-risk oncologic procedures. Patient selection was important in achieving observed outcomes. High complication rat...

Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/15/12/1520.full
Crawford, J.,et al

Nov 30th, 2017 - Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimen- and patie.

see more →

Drugs  2 results see all →

Clinicaltrials.gov  387 results

The impact of a tailored follow-up intervention on comprehensive geriatric assessment i...
https://doi.org/10.1016/j.jgo.2020.07.011
Journal of Geriatric Oncology; Ørum M, Eriksen SV et. al.

Jul 30th, 2020 - Comprehensive Geriatric Assessment (CGA) can identify health problems in older persons. In addition, CGA includes intervention towards the identified problems. With follow up, more problems may be identified and the interventions can be adjusted. ...

Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300499
Clinical Pharmacology and Therapeutics; Holstein SA, Vose JM

Jun 2nd, 2020 - Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.|2020|Holstein SA,Vose JM,|

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Changing Oncology Treatment Paradigms in the COVID-19 Pandemic.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224660
Clinical Colorectal Cancer; Lou E, Subramanian S

May 18th, 2020 - Changing Oncology Treatment Paradigms in the COVID-19 Pandemic.|2020|Lou E,Subramanian S,|

Cautious optimism-the current role of immunotherapy in gastrointestinal cancers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193996
Current Oncology (Toronto, Ont.); Mendis S, Gill S

May 5th, 2020 - Immunotherapy has been described as the "fourth pillar" of oncology treatment, in conjunction with surgery, chemotherapy, and radiotherapy. However, the role of immunotherapy in gastrointestinal tumours is still evolving. Data for checkpoint inhib...

see more →

News  29 results

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Oncologists agree with AI treatment decisions about half the time
https://www.mdedge.com/fedprac/avaho/article/206866/breast-cancer/oncologists-agree-ai-treatment-decisions-about-half-time?channel=263
Will Pass

Aug 22nd, 2019 - When it comes to treatment recommendations for high-risk breast cancer, oncologists agree with a leading artificial intelligence platform about half the time, according to investigators. In the first study of its kind, involving 10 Chinese oncolog.

Electronic health records linked to lower patient safety
https://www.mdedge.com/fedprac/avaho/article/199676/practice-management/electronic-health-records-linked-lower-patient?channel=263
Caleb Rans

Apr 26th, 2019 - Higher reliance on electronic health records (EHRs) in ambulatory oncology practice was significantly associated with reduced safety actions among oncology nurses and prescribers, according to results of a statewide survey. “The purpose of this st.

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive summary of an ASTRO Consensus Paper
https://www.practicalradonc.org/article/S1879-8500(18)30353-9/abstract
Wright,J.,et al

Jan 20th, 2019 - Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring perfor...

ASTRO Consensus Statement on Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive Summary
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Contouring-Consensus-Guidance-Document

Jan 20th, 2019 - This document provides tabled recommendations for normal tissues contouring during external beam treatment planning for each anotomical site in all definitive cases and those that should be considered in specific clinical scenarios. Additionally, ...

see more →